Your browser doesn't support javascript.
loading
The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension.
Morikawa, Masato; Mitani, Yoshihide; Holmborn, Katarina; Kato, Taichi; Koinuma, Daizo; Maruyama, Junko; Vasilaki, Eleftheria; Sawada, Hirofumi; Kobayashi, Mai; Ozawa, Takayuki; Morishita, Yasuyuki; Bessho, Yasumasa; Maeda, Shingo; Ledin, Johan; Aburatani, Hiroyuki; Kageyama, Ryoichiro; Maruyama, Kazuo; Heldin, Carl-Henrik; Miyazono, Kohei.
Afiliación
  • Morikawa M; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Mitani Y; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Box 582, Biomedical Center, Uppsala University, SE-751 23 Uppsala, Sweden.
  • Holmborn K; Ludwig Institute for Cancer Research, Science for Life Laboratory, Box 595, Biomedical Center, Uppsala University, SE-751 24 Uppsala, Sweden.
  • Kato T; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  • Koinuma D; Genome Engineering Zebrafish Facility, Science For Life Laboratory, Uppsala University, SE-752 36 Uppsala, Sweden.
  • Maruyama J; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  • Vasilaki E; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Sawada H; Department of Anesthesiology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  • Kobayashi M; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Box 582, Biomedical Center, Uppsala University, SE-751 23 Uppsala, Sweden.
  • Ozawa T; Ludwig Institute for Cancer Research, Science for Life Laboratory, Box 595, Biomedical Center, Uppsala University, SE-751 24 Uppsala, Sweden.
  • Morishita Y; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  • Bessho Y; Department of Anesthesiology, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan.
  • Maeda S; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Ledin J; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Aburatani H; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Kageyama R; Institute for Frontier Life and Medical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
  • Maruyama K; Department of Medical Joint Materials, Kagoshima University, Kagoshima, Kagoshima 890-8544, Japan.
  • Heldin CH; Genome Engineering Zebrafish Facility, Science For Life Laboratory, Uppsala University, SE-752 36 Uppsala, Sweden.
  • Miyazono K; Genome Science Division, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, Meguro-ku, Tokyo 153-8904, Japan.
Sci Signal ; 12(607)2019 11 12.
Article en En | MEDLINE | ID: mdl-31719172
Dysregulated bone morphogenetic protein (BMP) signaling in endothelial cells (ECs) is implicated in vascular diseases such as pulmonary arterial hypertension (PAH). Here, we showed that the transcription factor ATOH8 was a direct target of SMAD1/5 and was induced in a manner dependent on BMP but independent of Notch, another critical signaling pathway in ECs. In zebrafish and mice, inactivation of Atoh8 did not cause an arteriovenous malformation-like phenotype, which may arise because of dysregulated Notch signaling. In contrast, Atoh8-deficient mice exhibited a phenotype mimicking PAH, which included increased pulmonary arterial pressure and right ventricular hypertrophy. Moreover, ATOH8 expression was decreased in PAH patient lungs. We showed that in cells, ATOH8 interacted with hypoxia-inducible factor 2α (HIF-2α) and decreased its abundance, leading to reduced induction of HIF-2α target genes in response to hypoxia. Together, these findings suggest that the BMP receptor type II/ALK-1/SMAD/ATOH8 axis may attenuate hypoxic responses in ECs in the pulmonary circulation and may help prevent the development of PAH.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Receptores de Activinas Tipo II / Proteínas Smad / Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico / Hipertensión Pulmonar / Hipoxia Límite: Animals / Humans Idioma: En Revista: Sci Signal Asunto de la revista: CIENCIA / FISIOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Receptores de Activinas Tipo II / Proteínas Smad / Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico / Hipertensión Pulmonar / Hipoxia Límite: Animals / Humans Idioma: En Revista: Sci Signal Asunto de la revista: CIENCIA / FISIOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos